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Many Artificial Intelligence systems depend on the agent's updating its beliefs about the world on the basis 
of experience. Experiments constitute one type of experience, so scientific methodology offers a natural 
environment for examining the issues attendant to using this class of evidence. This paper presents a 
framework which structures the process of using scientific data from research reports for the purpose of 
making decisions, using decision analysis as the basis for the structure, and using medical research as the 
general scientific domain. The structure extends the basic influence diagram for updating belief in an object 
domain parameter of interest by expanding the parameter into four parts: those of the patient, the 
population, the study sample, and the effective study sample. The structure uses biases to perform the 
transformation of one parameter into another, so that, for instance, selection biases, in concert with the 
population parameter, yield the study sample parameter. The influence diagram structure provides decision 
theoretic justification for practices of good clinical research, such as randomized assignment and blindfolding 
of care providers. The model covers most research designs used in medicine: case-control studies, cohort 
studies, and controlled clinical trials, and provides an architecture to separate clearly between statistical 
knowledge and domain knowledge. The proposed general model can be the basis for clinical 
epidemiological advisory systems, when coupled with heuristic pruning of irrelevant biases; of statistical 
workstations, when the computational machinery for calculation of posterior distributions is added; and of 
metaanalytic reviews, when multiple studies may impact on a single population parameter. 
1 The Problem 
Decision-analytic models have been applied to 
different areas in artificial intelligence, including 
diagnosis (Heckennan, Horvitz, & Natbwani, 1989), 
learning (Star, 1987; Buntine, 1987), vision (Levitt, et 
al., 1988), and control of inference (Horvitz, 1989; 
Breese & Fehling, 1988). An activity common to these 
models is the agent's updating his belief in relevant 
propositions on the basis of evidence. The models 
usually leave implicit the decision maker's belief in the 
method by which the data were obtained. To be done 
properly, updating must include this belief in each of 
many possible models of observation of the data. We 
shall show that, in certain contexts, the space of all 
possible observational contexts can be parameterized to 
be both assessable and computable. Scientific research 
is one such context; specific biases· can be used to 
provide the necessary parameterization. 
Parameterization of the observational contexts is 
domain-dependent at different levels of the meaning of 
domain. We use the following hierarchy. The topmost 
level is the general field of scientific or systematic 
observation. The second level is the field of research 
aimed at discerning causal relations, as opposed, say, to 
exploratory descriptions. A third level is that of 
medical research, which eliminates from consideration a 
number of destructive experimental designs. A fourth 
level is the class of study, including, for instance, 
balanced-design, case-control, cohort, or randomized, 
studies. A fifth level is the object (domain of interest), 
such as cardiology. Our goal is to offer a structure that 
allows parameterization of all studies within the fourth 
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domain. A successful parameterization at this level 
should enable us to handle a wide variety of medical 
(object) domains, while the structure will probably be 
effective at higher levels as well. 
We may visualize the problem using the influence 
diagrams (Howard & Matheson, 1981) of Figure l. 
Figure la shows that the decision maker makes his 
decision, D, knowing the data, x, at the time of the 
decision, and thinking about the effect of the parameter, 
e, on relevant outcomes, Q, which affect the value, V, 
of the decision maker. The calculation of expected 
utility for the decision requires the prior probability 
distribution for the parameter e, in addition to the 
preposterior distribution P(x I 8). This formulation, 
however, leaves out the possibility that the data were 
obtained in different ways, which is equivalent to its 
preventing the decision maker from modeling his 
uncertainty in the preposterior distribution. In Figure 
lb, we include the observational context explicitly, 
operationalized (or parameterized) in terms of a bias 
parameter, <f>, and make explicit the types of data, y, 
that bear on rp, separately from those that bear on 8. To 
use this structure, we need the prior over ¢1 and the 
preposterior distribution, P(x I 8, ¢1 ). The latter 
distribution contains our knowledge about the 
mechanism by which the data are obtained in a 
particular experimental context. 
As an example of the importance of the 
observational context, consider the following problem. 
I have two coins, one of which I may bring to a 
gambling event. I would, of course, prefer the coin that 
gives me the greatest odds of winning me the most 
money. The coins are apparently identical, but they 
may have different chances of landing heads. I flip each 
coin 100 times, asking an assistant to give me the 
coins alternatingly. This process gives me two lists of 
tosses and outcomes, one for each coin. Most utility 
functions would have me choose the coin with the 
higher number of heads as the coin to take (unless that 
proportion is too high, in which case I risk being found 
(J Parameter of interest 
x Data pertaining to parameter of interest 
D Decision 
n Outcomes 
V Value 
Y Data pertaining to !lias parameter 
� Bias parameter 
Figure 1. General influence�diagram models for belief 
updating. (a) Using primary data t o  update belief in 
the parameter of interest. (b) Parameterizing the 
observational context and using additional data to 
update belief in the observational model. 
out as a cheater), based on the binomial likelihood: for 
i = I ,2, the posterior probability of e; (the chance of 
coin i falling heads) given Xi (the observed number of 
heads from flipping coin i) is proportional to 
e; (1-e; )100-x;, and this might be your advice to me. 
But what if I told you that my assistant is three years 
old? You might reconsider your advice, since the 
assumption that each list pertains to a separate coin is 
now probably invalid. We should introduce two new 
parameters, ¢>;, which represent the proportion of the 
time our young assistant gave me coin i, but told me it 
was the other one. The correct model for the 
preposterior function for XI now is 
z (x; 1 er > = 81x; o-entOO-x;, 
where fJ{, the effective parameter, is a function of Ot, 
lh, fPt. and lh, Specifically, 
Bj = OtO- ¢>t)+fl2¢>2. 
To find the posterior distribution of e; given the data, 
we must integrate out the observational parameters. 
Alternatively, we could ask, what shape of a prior over 
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the observational parameters would lead to a change in 
action? 
2 A Model for the lJse of Reoorted Scientific 
llil1a 
We narrow our attention to study designs for 
medical research, at the fourth level of our domain 
hierarchy, for a number of reasons. First, providing 
data for high-stakes decisions relating to individual 
situations is a major purpose of medical research, as 
evidenced by the large number of clinical studies. 
Second, while our discussion will remain general, it 
will be focused by our considering a narrower domain 
than all scientific research, thereby clarifying the model. 
Third, the concept of bias in medical research is well 
established, giving us a baseline against which to judge 
the external validity of our model. 
2.1 Details of the General Model 
Our general model, depicted in Figure 2, is an 
expansion of Figure 1, based on Shachter, et al. (1989). 
It consists of a central framework with peripheral 
adjustments. The framework allows the representation 
of a number of modeling decisions, separate from the 
domain issue of which therapy to implement. We will 
point out these modeling decisions as they come up. 
One general approach for making modeling decisions is 
for the physician to explore each potential model 
resulting from one modeling decision, and integrate 
expected value across these models, weighted by a prior 
probability on each model. A second approach is for 
the physician to perform a sensitivity analysis across 
some or all models, and either continue with a single 
best model, or integrate across models, depending on the 
outcome of the analysis. 
We now circWlUlavigate our general model, Figure 
2. We have made explicit that the physician is 
concerned about a particular Outcome of Interest, such 
as mortality, morbidity, or cost The fact that he uses 
certain parameters to help him assess the likelihood of 
that outcome occurring is a result of a separate decision 
as to the probabilistic model he chooses to use. 
We have split the general Parameter of Interest, fJ, from 
Figure 1 into four separate parameters: the Patient 
Parameter, Bpt• the Population Parameter, Bpop• the 
Sample Parameter, flsample· and the Effective Sample 
Parameter, B'samp!e.. By separating ept from Bpop. we 
allow the physician to take two types of modeling 
actions. One is for the physician to use the same data 
for many different clinical situations, if he knows how 
to derive the distribution for Bpt from Hyperparameters 
updated by epop in a hierarchical Bayes framework 
(Berger, 1985), which may require traditional statistical 
models. A second type of modeling action is for him 
toeffect a metaanalysis (L 'AbM, 1987), using multiple 
sources of data (several different papers) to update his 
Medical 
DecisitJn 
Figure 2. Influence-diagram model for using research data in the general medical decision-making problem. 
belief in Bpop· By separating Bsample from Opop• we The Data node of Figure 1 has been split into an 
allow for the physician to generalize the study from Experimental Outcome node, representing the actual 
Osample• the belief in the parameter for the perfectly- results from the study as perfonned; an Observed Data 
done study, to Bpop• the belief in the parameter for the node, representing the data recorded by the 
ideal population. The physician could calculate experimenters; and a Reported Data node, representing 
Osample exactly from 6pop, if  he knew how the the data �s reported in the written article and the only 
Selection from the general population led to the patient data �vallable to the reader. The likelihood of the 
pool sampled in the study and by what Protocol Design experunen�al outcome given the Effective Sample 
the patients were assigned their respective interventions Parameter ts the probability distribution that depends on 
(which is why Bsample is a deterministic node). The 
the P�obabilistic Model the physician chooses for 
last parameter, e'sample· contains the physician' s 
mo�lmg the outcome of �e expe�ent. For ?Io�lity 
belief in the parameter of the study as perfonned. If the studies, as an e��ple, thts model ts usually bmorrual. 
physician knew exactly bow e 1 was modified by If the ph_ystctan knew the Measurement Reliability 
the experimental Protocol lm;::�;ntation he could 
of th� r�ording instruments, say the true sensitivity and 
calculate exactly what the parameter was to 
'
which the 
specifiCity, and tlle true model relating the reliability to 
experimental outcome refers. 
the actual and the observed data, he could calculate 
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exactly the Observed Data from the Experimental 
Outcome. Si..ntilarly, if he knew exactly the Credibility 
of the reporters, he could calculate the Reported Data 
from the Observed Data. 
Researchers often report in their papers only their 
estimate of the parameter, rather than all the observed 
data. This estimate is a Statistical Function of the 
observed data, such as a mean or a regression 
coefficient. Statistical decision theory (Berger, 1985) 
concerns itself with the choice of that function. We 
note that, without at least the observed data, we lose 
information that could potentially alter our decision. 
The sufficient statistics proposed by statistical decision 
theory, then, appear to be context dependent, and our 
model makes explicit just this context. 
2.2 An Example of Navigating the Model 
To illustrate how all this might work in a specific 
instance, we consider a 55 year old white woman who 
has just had a heart attack and who has been brought 
into the hospital almost immediately after symptoms of 
chest pain, nausea, and sweating set in. Her physician, 
besides needing to stabilize her acute cardiovascular 
status, wants to prevent worsening of her general cardiac 
condition. The doctor knows that a drug, metoprolol, 
is considered possibly able to do so. He is primarily 
concerned with minimizing the patient's chance of 
death, and thereby maximizing the heart attack victim's 
life expectancy. There are some known side effects of 
the medication. Should he use the drug? 
Let us go through an abbreviated analysis using a 
study (Hjalmarson, et al., 1980) that bears on this 
question. As discussed before, we leave the choice of 
the value model to be implicit. The Outcome of 
Interest is mortality. We make the modeling decision 
to use the patient's probability of death as the Patient 
Parameter, which we will asswne to be constant over 
time (constant hazard model). For the modeling 
decision of the choice of referent Population, we have at 
least two choices on the basis of cardiology-domain 
knowledge: middle-aged worren and middle-aged adults. 
If we choose the population of both sexes, there will be 
a larger number of studies, each with a large sample 
size, that we can bring to bear on this problem, which, 
in concert, may affect the Hyperparameters as much as 
if we used only the subgroup of women only. Clearly, 
there is a modeling decision trade-off between specificity 
of the data versus its the amount of data available. For 
the purposes of this paper, we shall take the modeling 
action of using only the combined population of 
middle-aged adults. 
The Sa mple in the study consists of all heart­
attacks victims from south Sweden in the late 1970s. 
This characterization represents Selection from our 
population on ethnic grounds, but not on the basis of 
referral, diagnostic purity, or diagnostic access biases 
(Sackett, 1979). The Protocol Design is reported to 
have been that of a double-blinded and randomized 
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clinical trial, in which the assignment of a patient t o  a 
given treatment is independent of the patient' s baseline 
status. There is evidence to support the claim that the 
Protocol Implementation was identical to the design. 
For instance, the compositions of the metoprolol and 
placebo groups are similar with respect to relevant 
characteristics, based on reported baseline data, 
corroborating the implementation of randomization. 
The number of withdrawals from the study on the basis 
of side-effects is also similar between the two groups, 
suggesting that if there were some unblindfolding of the 
care providers such that the treating physicians became 
aware of the true treatment assignments, its degree was 
the same in both groups. 
Estimating the actual degree of withdrawal 
explicitly is important for calculating a posterior 
distribution on &sample· Withdrawal refers to a 
patient's not receiving the treatment to which he was 
assigned. This estimation adds a bias parameter to be 
inferred, which, in tum, results in our considering a 
space of observational models larger than we would be 
considering without including the withdrawal bias. The 
withdrawal bias parameter in this study models the fact 
that the effective sample parameter for metoprolol was a 
result of mixing the treatment group with a third group 
of patients receiving no treatment, that is, a group with 
the baseline mortality risk (the group of patients 
w ithdrawn). The new parameter to be inferred is the 
degree of mixing, ¢. Shachter and colleagues (1989) 
offer a mathematical form for the effective sample 
parameter, 
&'sample, metoprolol 
( 1 
-
¢) · &sample, metoprolol 
+ ¢ · &sample, baseline. 
showing that &'sample· is a function of &sample and of 
¢>, as represented by the deterministic node in Figure 2. 
We note the similarity to our coin problem, in Section 
1, where now, ¢>1=rh=¢>. In the study, the reported 
overall withdrawal rate is 19.1 per cent in both groups, 
and we could use this to update our belief in ¢. 
Continuing around Figure 2, we find that the 
investigators use the binomial Probabilistic Model, in 
keeping with our definition of the parameter of interest. 
Measurement Reliability depends on the sensitivity and 
the specificity of the sensing mechanisms. For 
mortality studies, the sensitivity, P(labeling patient as 
"dead" I patient deceased), and specificity, P(labeling t!JR 
patient as "alive" I patient is alive), depend on patients 
who have dropped out of the study. The authors assure 
us that the mortality status of each patient entered into 
the study was assessed, regardless of subsequent 
treatment status, and their credentials are such that we 
c onsider them to have high Credibility. Finally, the 
authors report both mortality rates and life tables as 
their Statistical Functions of the data. 
3 Usine Bias to Parameterize the Space of 
Clinical Studies 
We now have the basic architecture for 
parameterizing the space of observational models 
through expanding the peripheral nodes of Figure 2. 
We gave the details of one instance in the mixture 
model resulting from patients withdrawn from the 
study. Our present concern is simply to locate all 
potential biases in a single model. We wish, therefore, 
for as comprehensive as possible a set of biases that 
spans the space of all studies. To show this set, we 
need to examine more closely the top line of Figure 2: 
the relationships among 8p0p, Bsample· and B'sample· 
In causal studies, each of these parameters is a 
probability (e.g., mortality risk), or a parameter of a 
probability distribution, and hence represents an 
abstraction of a local node group of an influence 
diagram. The most general form of such a local node 
group is given in Figure 3: the node Patient's Event is 
dependent on the nodes Patient's Baseline State and 
Patient's Exposure to an Agent of Interest. F o r  
instance, Bsample i s  defined b y  the probability 
distribution of the events observed in the sample 
patients, given the baseline states of the sample patients 
and the agents to which those patients were exposed. 
Similarly for the population and for the effective 
sample. The language comes from Feinstein (1985), 
who uses this local node group to account for the widest 
possible range of initial states (e.g., healthy, diseased), 
agents (e.g., environmental exposure, medical therapy, 
process intervention), and events (e.g., mortality, pain, 
contraction of disease), thereby allowing for the same 
structure to be used in analyzing the entire class of 
comparative studies. Thus, to explore the relationship 
between specific biases and the parameter in which we 
are interested, we need to examine the primary belief 
network of which the parameter is an abstraction, and to 
locate the dependencies of the parameter on those biases. 
Then, the relationship between two parameters can be 
worked out at the level of these primary local node 
groups. 
In Figure 4, we present a fragment of such an 
expanded belief network, showing the interplay between 
different classes of bias and the relationship between the 
Sample Parameter and the Effective Sample Parameter. 
The citation sources for the biases are indicated. As an 
example, we note that Classification Error is a class of 
bias upon which the assessment of Effective Sample 
Initial State is dependent. There is a large list of 
specific biases which fall into this category, such as 
Previous Opinion Bias and Diagnostic Suspicion Bias. 
These biases lead to an difference between the Sample 
Initial State and the Effective Sample Initial State; this 
difference leads, in turn to a difference between the 
Sample Parameter and the Effective Sample Parameter. 
This fragment, then, is the mechanistic interpretation 
(or, expansion) of the arc in Figure 2 between the 
Sample Parameter and the Effective Sample Param£ter. 
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We note that the model incorporates a wide variety 
of methodological elements, such as misclassification, 
misassignment, and conduction of the study 
(blindfolding) all into a single model. This analysis of 
mechanism allows us to preserve (or define) the 
semantics of the biases, while providing a numerical 
environment in which to use them. 
4 Previous Attempts to Model the Use of 
Scientific Data 
Rennels (1986) uses AI heuristics in constructing a 
system, ROUNDSMAN, that offers therapeutic 
suggestions for a particular patient, on the basis of 
articles in its knowledge base. The primary heuristic is 
the calculation of the "distance" of a paper to a 
particular domain decision. For the program to 
function, a domain expert must pre-process each article; 
the user enters the defining characteristics for the 
patient. Problematic in Rennels' approach is that all 
types of biases and adjustments are combined into a 
single score, without an underlying structure like the 
one we have developed. Furthermore, by not 
considering the probabilistic model for the data, 
ROUNDSMAN is unable to give an integrated numeric 
solution to the question of what the physician should do 
on the basis of the data. 
Figure 3. The general local node group of which a 
parameter of interest (such as the Population Parameter) 
represents the indicated probability distribution After 
Feinstein (1985). 
Our model is in the same spirit as Eddy's 
confidence prof:tle method (Eddy, 1989). His approach is 
motivated more by the desire to perform metaanalyses 
than the need to analyze in depth a single article. His 
"chains" are concerned with the causal connections 
between parameters and outcomes of interest. He deals 
with biases as correction factors, similar to our 
peripheral nodes in Figures 2 . 
The goal of the REFEREE research endeavor 
(Lehmann, 1988) is to create a system that aids a user 
in evaluating the methodological quality of a paper. 
The REFEREE team first implemented that goal in a 
rule-based program. Because of semantic and 
representational deficiencies, they redefined the goal to 
be the replicability of the conclusion of the study, and 
Procedure S.el.e �on• 
Apprehension 
Obsequious ness* 
Expectation• 
implemented the new goal in a probabilistic program 
and in a multiattribute-value-based program. However, 
even with these normative bases, it is not clear what 
should be done with the output of these systems. The 
approach we have taken in this paper is an answer to 
that question. 
Figure 4. Primary influence diagram. defining the Effective Sample Parameter, and its relationship to the Sample Parameter. 
Thickly drawn nodes and arcs indicate the local node groups of Figure 3. The horizontally hatched arcs indicate that the 
destination node is a n  abstraction of the probability distribution of the des tination node. Footnote symbols indicate citation 
sourcefor biases: * Sackett (1979); t Feinstein ( 1985); 1 Lehmann ( 1988). 
Finally, the field of clinical epidemiology is 
"concerned with studying groups of people to achieve 
the background evidence needed for clinical decisions in 
patient care" (Feinstein 1985, p. l). Besides bringing 
epidemiological and statistical techniques to the medical 
bedside, clinical epidemiologists are concerned with 
physicians' coherent reading of the clinical research 
literature. Sackett, Haynes, and Tugwell (1985) have 
published a sequential algorithm for using the 
literature: If the article fails any step along the path, it 
is eliminated from consideration. L'Abbe, Detsky, and 
O'Rourke (1987) describe sequential steps to be taken 
for using an article in a metaanalysis. Their measure of 
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quality is based on the rating-sheet approach of 
Chalmers and colleagues (1981 ). Our approach, in 
contrast, is global in that an article is implicitly 
discarded only after the probability distribution, P(ept I 
Reported Data), is determined; a distribution close to the 
prior distribution over ept suggests that the biases and 
adjustments have washed out any meaningfulness from 
the reported data. The primary advantage of the global 
approach is that it does not explicitly throw out data, 
unlike the sequential algorithm. Although a study may 
be designed and executed poorly or may be somewhat 
irrelevant, its data may still have an important bearing 
on the calculation of expected value. The disadvantage 
of the global approach is its computational complexity. 
5 Uses of the Model 
The model may be used in several ways. At the 
least, it may help a reader to organize the study of 
research results. This use leads to a qualitative analysis 
that, alone, may result in all the insights the user may 
want. We focus our comments on computer 
applications, however. A quantitative approach helps 
a user to organize the clinical epidemiological concerns 
and provides the basis for a decision support system and 
statistical workstation, where the resulting probability 
distributions may be displayed and studied, and where 
distributions over probability models may be considered 
as well. 
In using the model to construct decision-support 
systems, we must construct models of how evidence in 
the study report updates our belief in a model. 
Extending the model results in our building a large 
knowledge base of research designs. With our general 
layout of the space of studies, it becomes easier to 
accrue new biases and research designs. The model we 
have given serves as the core, the methodological and 
statistical knowledge base (Figure 5). Domain 
knowledge is incorporated as new conditions on the 
biases (new predecessors), or new sources of evidence 
for the different biases (new descendents). In using the 
model, we begin with the knowledge base of biases, and 
use either methodologic or object-domain knowledge 
heuristically to prune that KB on the basis of which 
biases are irrelevant for the context of interest. With 
this reduced model, we then expand the possible 
evidential nodes for the bias parameters and search for 
evidence in the study report that bears on the bias 
parameters. Once we have updated our belief in those 
parameters, we examine the primary data themselves, 
which update both the bias parameters and the domain 
parameter. Finally, we remove the bias parameters as 
nuisance parameters. Shachter (1988) gives the general 
approach for this, and Barlow, Irony, and Shor (1988) 
give an example pertaining to experimental designs. 
This removal leaves us with a posterior probability 
distribution on the Population Parameter. We then 
derive the distribution for the Patient Parameter and 
calculate the expected utility for each action. We may 
do the reverse as well, and ask: what prior probability 
distribution would have us take different action? 
We have presented an architecture for a large 
knowledge base of science methodology. The details of 
this knowledge base have implications for designing 
scientifically (rationally) functioning computer agents 
which collect data about the real world. The model we 
have presented eliminates most theoretical problems 
with previous approaches and provides a framework for 
future work. Extensions of our ideas include 
generalizing to other evidential domains in the hierarchy 
of domains presented at the beginning of this paper. 
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Domian·dependenl 
Condilwning 
Knowledge 
Methodological 
and Statistical 
Knowledge 
Domain-dependent 
Evidential 
Knowledge 
Figure 5. General architecture for a decision support 
system. The central knowledge base contains 
methodological and statistical knowledge of biases and 
of the decision process (as in Figures 1, 2, and 3). The 
upper knoweldge base contains domain-specific 
knowledge regarding conditioning k nowledge for 
specific biases, while the lower one contains 
domain-specific knowledge about what sorts of 
information from a study are evidential for specific 
biases. 
We also need to make more explicit the various 
modeling decisions the reader undertakes in performing 
the type of analysis we have been discussing. The work 
we present here can be followed now by a practical 
instantiation. 
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